UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of ipragliflozin on liver function in Japanese type 2 diabetes mellitus patients: subgroup analysis of a 3-year post-marketing surveillance study (STELLA–LONG TERM)

Endocrine Journal, 2021, Vol.68(8), pp.905-918

2021

Volltextzugriff (PDF)

Effect of ipragliflozin on liver function in Japanese type 2 diabetes mellitus patients: a subgroup analysis of the STELLA-LONG TERM study (3-month interim results)

Endocrine Journal, 2019, Vol.66(1), pp.31-41

2019

Volltextzugriff (PDF)

Bayesian Latent Class Models for Evaluating the Validity of Claim-based Definitions of Disease Outcomes

Annals of Clinical Epidemiology, 2024/10/01, Vol.6(4), pp.77-86

2024

Volltextzugriff (PDF)

Anticholinergic burden in the Japanese elderly population: Use of antimuscarinic medications for overactive bladder patients

International journal of urology, 2018-10, Vol.25 (10), p.855-862

2018

Volltextzugriff (PDF)

Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study

Advances in therapy, 2019-04, Vol.36 (4), p.923-949

2019

Volltextzugriff (PDF)

Correction to: Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study

Advances in therapy, 2021-08, Vol.38 (8), p.4599-4601

2021

Volltextzugriff (PDF)

Persistence and adherence to overactive bladder medications in Japan: A large nationwide real‐world analysis

International journal of urology, 2017-10, Vol.24 (10), p.757-764

2017

Volltextzugriff (PDF)

Safety and effectiveness of ipragliflozin in Japanese patients with type 2 diabetes mellitus and impaired renal function: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM)

Diabetology international, 2021-04, Vol.12 (2), p.181-196

2021

Volltextzugriff (PDF)

Real-world evidence for long-term safety and effectiveness of ipragliflozin in treatment-naïve versus non-naïve Japanese patients with type 2 diabetes mellitus: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM)

Diabetology international, 2021-10, Vol.12 (4), p.430-444

2021

Volltextzugriff (PDF)

The Effect of Patient Age on Anticholinergic Use in the Elderly Japanese Population —Differences between Four Anticholinergic Scales

YAKUGAKU ZASSHI, 2020/05/01, Vol.140(5), pp.701-710

2020

Volltextzugriff (PDF)

Impact of body mass index on the efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes mellitus: A subgroup analysis of 3‐month interim results from the Specified Drug Use Results Survey of Ipragliflozin Treatment in Type 2 Diabetic Patients: Long‐term Use study

Journal of diabetes investigation, 2019-09, Vol.10 (5), p.1262-1271

2019

Volltextzugriff (PDF)

Safety, efficacy, and persistence of long‐term mirabegron treatment for overactive bladder in the daily clinical setting: Interim (1‐year) report from a Japanese post‐marketing surveillance study

Lower urinary tract symptoms, 2019-01, Vol.11 (1), p.14-23

2019

Volltextzugriff (PDF)

Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study

International journal of clinical oncology, 2022-10, Vol.27 (10), p.1632-1643

2022

Volltextzugriff (PDF)

Nationwide surveillance of bacterial pathogens isolated from patients with acute uncomplicated cystitis in 2018: Conducted by the Japanese Research Group for Urinary Tract Infections (JRGU)

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2021-08, Vol.27 (8), p.1169-1180

2021

Volltextzugriff (PDF)

Antimicrobial susceptibilities of Chlamydia trachomatis isolated from the urethra and pharynx of Japanese males

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017-08, Vol.23 (8), p.512-516

2017

Volltextzugriff (PDF)

Second nationwide surveillance of bacterial pathogens in patients with acute uncomplicated cystitis conducted by Japanese Surveillance Committee from 2015 to 2016: antimicrobial susceptibility of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus saprophyticus

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019-06, Vol.25 (6), p.413-422

2019

Volltextzugriff (PDF)

Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan: Comparison with the first surveillance report

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022-01, Vol.28 (1), p.1-5

2022

Volltextzugriff (PDF)

The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012–2013

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015-05, Vol.21 (5), p.340-345

2015

Volltextzugriff (PDF)

Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration‐resistant prostate cancer: AFTERCAB study

BJUI compass, 2022-01, Vol.3 (1), p.26-36

2022

Volltextzugriff (PDF)

Nationwide surveillance of bacterial pathogens from patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2009 and 2010: antimicrobial susceptibility of Escherichia coli and Staphylococcus saprophyticus

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013-06, Vol.19 (3), p.393-403

2013

Volltextzugriff (PDF)

Bayesian Latent Class Models for Evaluating the Validity of Claim-based Definitions of Disease Outcomes

Annals of Clinical Epidemiology, 2024, pp.24012

2024

Volltextzugriff (PDF)

Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016-09, Vol.22 (9), p.581-586

2016

Volltextzugriff (PDF)

Firth‐Type Penalized Methods of the Modified Poisson and Least‐Squares Regression Analyses for Binary Outcomes

Biometrical journal, 2024-10, Vol.66 (7), p.e202400004-n/a

2024

Volltextzugriff (PDF)

Alteration in plasma protein binding properties of propranolol and flurbiprofen during development of adjuvant-induced arthritis in rats

Xenobiotica, 2013-03, Vol.43 (3), p.246-252

2013

Volltextzugriff (PDF)

Update on Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: 3-Year Postmarketing Surveillance Follow-Up in Japan

Journal of rheumatology, 2024-09, p.jrheum.2024-0379

2024

Volltextzugriff (PDF)

1 – 25 von 913

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(651)
Mit Volltextzugriff
(717)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Effect of ipragliflozin on liver function in Japanese type 2 diabetes mellitus patients: subgroup analysis of a 3-year post-marketing surveillance study (STELLA–LONG TERM)

Effect of ipragliflozin on liver function in Japanese type 2 diabetes mellitus patients: a subgroup analysis of the STELLA-LONG TERM study (3-month interim results)

Bayesian Latent Class Models for Evaluating the Validity of Claim-based Definitions of Disease Outcomes

Anticholinergic burden in the Japanese elderly population: Use of antimuscarinic medications for overactive bladder patients

Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study

Correction to: Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study

Persistence and adherence to overactive bladder medications in Japan: A large nationwide real‐world analysis

Safety and effectiveness of ipragliflozin in Japanese patients with type 2 diabetes mellitus and impaired renal function: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM)

Real-world evidence for long-term safety and effectiveness of ipragliflozin in treatment-naïve versus non-naïve Japanese patients with type 2 diabetes mellitus: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM)

The Effect of Patient Age on Anticholinergic Use in the Elderly Japanese Population —Differences between Four Anticholinergic Scales

Impact of body mass index on the efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes mellitus: A subgroup analysis of 3‐month interim results from the Specified Drug Use Results Survey of Ipragliflozin Treatment in Type 2 Diabetic Patients: Long‐term Use study

Safety, efficacy, and persistence of long‐term mirabegron treatment for overactive bladder in the daily clinical setting: Interim (1‐year) report from a Japanese post‐marketing surveillance study

Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study

Nationwide surveillance of bacterial pathogens isolated from patients with acute uncomplicated cystitis in 2018: Conducted by the Japanese Research Group for Urinary Tract Infections (JRGU)

Antimicrobial susceptibilities of Chlamydia trachomatis isolated from the urethra and pharynx of Japanese males

Second nationwide surveillance of bacterial pathogens in patients with acute uncomplicated cystitis conducted by Japanese Surveillance Committee from 2015 to 2016: antimicrobial susceptibility of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus saprophyticus

Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan: Comparison with the first surveillance report

The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012–2013

Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration‐resistant prostate cancer: AFTERCAB study

Nationwide surveillance of bacterial pathogens from patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2009 and 2010: antimicrobial susceptibility of Escherichia coli and Staphylococcus saprophyticus

Bayesian Latent Class Models for Evaluating the Validity of Claim-based Definitions of Disease Outcomes

Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan

Firth‐Type Penalized Methods of the Modified Poisson and Least‐Squares Regression Analyses for Binary Outcomes

Alteration in plasma protein binding properties of propranolol and flurbiprofen during development of adjuvant-induced arthritis in rats

Update on Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: 3-Year Postmarketing Surveillance Follow-Up in Japan

Suchergebnisse filtern